These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies. Liu D; Wang C; Hora B; Zuo T; Goonetilleke N; Liu MKP; Berrong M; Ferrari G; McMichael AJ; Bhattacharya T; Perelson AS; Gao F Retrovirology; 2017 Oct; 14(1):46. PubMed ID: 29017536 [TBL] [Abstract][Full Text] [Related]
51. Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia. Yang OO; Daar ES; Ng HL; Shih R; Jamieson BD AIDS Res Hum Retroviruses; 2011 Apr; 27(4):391-8. PubMed ID: 21087140 [TBL] [Abstract][Full Text] [Related]
52. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. Fernandez CS; Stratov I; De Rose R; Walsh K; Dale CJ; Smith MZ; Agy MB; Hu SL; Krebs K; Watkins DI; O'connor DH; Davenport MP; Kent SJ J Virol; 2005 May; 79(9):5721-31. PubMed ID: 15827187 [TBL] [Abstract][Full Text] [Related]
53. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012 [TBL] [Abstract][Full Text] [Related]
54. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606 [TBL] [Abstract][Full Text] [Related]
55. Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques. Ishii H; Kawada M; Tsukamoto T; Yamamoto H; Matsuoka S; Shiino T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Naruse TK; Kimura A; Takiguchi M; Matano T J Virol; 2012 Jan; 86(2):738-45. PubMed ID: 22072784 [TBL] [Abstract][Full Text] [Related]
56. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253 [TBL] [Abstract][Full Text] [Related]
58. High frequency of CD8 escape mutations in elite controllers as new obstacle for HIV cure. Navarrete-Muñoz MA; Ramos R; Holguín Á; Cabello A; Górgolas M; Benito JM; Rallón N Virulence; 2022 Dec; 13(1):1713-1719. PubMed ID: 36190143 [TBL] [Abstract][Full Text] [Related]
59. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. Chopera DR; Woodman Z; Mlisana K; Mlotshwa M; Martin DP; Seoighe C; Treurnicht F; de Rosa DA; Hide W; Karim SA; Gray CM; Williamson C; PLoS Pathog; 2008 Mar; 4(3):e1000033. PubMed ID: 18369479 [TBL] [Abstract][Full Text] [Related]
60. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]